Retail sales have been a disappointment now for three consecutive months and as such this may lead to downward revisions for Q2 GDP estimates. While that remains to be seen, something simply isn’t resonating well with the consumer. Maybe it’s uncertainty surrounding the future of healthcare, maybe it’s simply the every rising costs of healthcare premiums that are syphoning off…
Since the S&P 500’s 8-day win streak ended on November 8th, I think we can say that the market...
Introduction The U.S. economy will struggle in 2023 with halting growth and higher unemployment. Recession is a serious threat....
There isn’t much ‘feeling’ on the part of bulls or bears these days. As discussed previously, with seven months...
If Risk Management is priority #1… Is that Opportunity Risk or is that Downside Risk? The threat from the...
What is next for markets? Investors should position forrising odds of Trump re-election In March, we were the first...
There are now at least 4 key ingredients drawing upon investor fears and which have resulted in a May,...
Welcome back ladies and gentlemen! This weekend’s Research Report will be abbreviated, as we maintain our outlook for 2024,...
Good weekend Finom Group investors/traders! While this is our off-reporting weekend, and we’ll be back at it again next...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
